Business Description
THC Farmaceuticals Inc
NAICS : 541714
SIC : 2834
ISIN : US87243T1007
Compare
Compare
Traded in other countries / regions
CBDG.USA IPO Date
2012-08-22Description
THC Farmaceuticals Inc is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and other medical disciplines. It offers the combination of proprietary developments with the expertise of clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.22 | |||||
9-Day RSI | 64.99 | |||||
14-Day RSI | 61.31 | |||||
3-1 Month Momentum % | -38.89 | |||||
6-1 Month Momentum % | -71.05 | |||||
12-1 Month Momentum % | 7.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -316.67 | |||||
OCF Margin % | -316.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -59.5 | |||||
EV-to-EBITDA | -79.33 | |||||
EV-to-Revenue | 39.67 | |||||
EV-to-FCF | -12.53 | |||||
Earnings Yield (Greenblatt) % | -1.68 | |||||
FCF Yield % | -4.37 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CBDG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
THC Farmaceuticals Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.006 | ||
| EPS (TTM) ($) | - | ||
| Beta | -32.5087 | ||
| 3-Year Sharpe Ratio | 0.71 | ||
| 3-Year Sortino Ratio | 10.91 | ||
| Volatility % | 204.12 | ||
| 14-Day RSI | 61.31 | ||
| 14-Day ATR ($) | 0.003784 | ||
| 20-Day SMA ($) | 0.012515 | ||
| 12-1 Month Momentum % | 7.84 | ||
| 52-Week Range ($) | 0.0022 - 0.093 | ||
| Shares Outstanding (Mil) | 18.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
THC Farmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
THC Farmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
THC Farmaceuticals Inc Frequently Asked Questions
What is THC Farmaceuticals Inc(CBDG)'s stock price today?
The current price of CBDG is $0.02. The 52 week high of CBDG is $0.09 and 52 week low is $0.00.
When is next earnings date of THC Farmaceuticals Inc(CBDG)?
The next earnings date of THC Farmaceuticals Inc(CBDG) is .
Does THC Farmaceuticals Inc(CBDG) pay dividends? If so, how much?
THC Farmaceuticals Inc(CBDG) does not pay dividend.
Guru Commentaries on OTCPK:CBDG
No articles.
Press Release
Articles on THC Farmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers